Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Clinical trial NCT02512497 · COMPLETED

Trial details

NCT number: NCT02512497
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma T-Prolymphocytic Leukemia T-Large Granulocytic Leukemia T-Lymphoblastic Leukemia/Lymphoma Peripheral T-Cell Lymphoma

Start date: 2017-12-08
Primary completion: 2023-10-06
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.